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Purpose: Azoospermia is defined as the absence of spermatozoa in the pellet of a centrifuged semen sample. In fact, when a
basic semen analysis fails to detect sperm in the ejaculate, there is still the possibility of detecting rare sperm after centrifugation of the sample and examination of the pellet. In this study, we assessed the role of Cytospin centrifugation in combination
with the nuclear fast picroindigocarmine (NF-PIC) staining in identifying sperm in azoospermic samples.
Materials and Methods: Semen samples of 251 men diagnosed as having azoospermia after standard examination were further analyzed by Cytospin centrifugation in combination with NF-PIC staining.
Results: Sperm were detected in 60 men (23.9%), thus changing their diagnosis to cryptozoospermia.
Conclusions: By identifying sperm in the semen of men who were thought to have total azoospermia, the Cytospin NF-PIC
test can alter the diagnosis and further treatment of these men.
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the Institutional Review Board (IRB) of the Cleveland
Clinic (Cleveland, OH, USA), the electronic medical record of the Cleveland Clinic was reviewed for the time
period between May 2015 and July 2021.

INTRODUCTION
Azoospermia, seen in approximately 10% to 15% of all
infertile men [1-3], is defined as the absence of sperm in
at least two different ejaculate samples, including in the
centrifuged sediments [4-6]. The purpose of centrifugation is to concentrate rare sperm present in the semen
into a compact pellet, thus making it possible to detect
cryptozoospermia [4-7]. Since the detection of rare sperm
depends on centrifugation, it is possible that using a different method of centrifugation and staining may detect
sperm in samples where no sperm were found initially.
The aim of this study is to assess whether using Cytospin centrifugation in combination with nuclear fast
picroindigocarmine (NF-PIC) staining can detect sperm
in semen samples that were labelled as azoospermic
when examined by the standard method recommended
by the World Health Organization (WHO) manual [5,6].

2. Data collection

We collected records of azooospermic men who underwent further testing using the Cytospin centrifugation combined with NF-PIC stain test, which was
developed in our laboratory [2]. The steps involved in
examining the semen sample for the presence of rare
spermatozoa are shown in Fig. 1. The outcome of the
NF-PIC test was noted as NF-PIC positive if sperm
were found, or as NF-PIC negative if no sperm were
found. Any additional clinical data available was also
recorded for possible secondary analysis.

3. Examination of semen sample

Routine semen analysis was conducted according to
WHO recommendations [5]. For examination of the semen sample, 6 µL of a completely liquefied sample was
loaded on a fixed 20 µm depth cell counting chamber
and observed under a phase contrast microscope using

MATERIALS AND METHODS
1. Ethics statement

Following approval of the project (IRB # 21-800) by

Routine semen analysis

No sperm seen on neat sample

Centrifuge the sample

Examine the wet sample for sperm

No sperm seen
(none-seen sample)

Rare sperm seen
(cryptozoospermia)

Proceed for special test
NF-PIC staining

Sperm seen

No sperm seen
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Fig. 1. Schematics showing steps in examining the semen sample for presence
of sperm. NF-PIC: nuclear fast picroindigocarmine.
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20× objective and a 10× eyepiece (total magnification
of 200) [8]. If no sperm were observed in a wet unspun
preparation, the sample was centrifuged at 3,000 g for
15 minutes. The supernatant was discarded and the
sperm pellet re-suspended in 50-μL of seminal plasma.
Two 6 µL aliquots were loaded on two wells of a fixed
cell counting chamber and carefully examined under
phase-contrast optics at 200× magnification for the
presence of the sperm. A diagnosis of cryptozoospermia
was established when sperm were found on examination of the replicates. Diagnosis of azoospermia was
confirmed by the absence of sperm on assessment of
the replicate wet preparations. If no sperm were observed, the sample was processed for cytocentrifugation.

4. Preparation of samples for cytocentrifugation
(Cytospin)

Cytospin is the process whereby cells are centrifuged
to be concentrated in a small area on the microscope
A

B

slide. This uses a bench-top centrifuge with a specially
designed rotor and sample chambers to deposit cells
onto a clearly defined area of the slide. In order to
perform the Cytospin procedure, we used a Cytospin
centrifuge (Cytospin 4; Thermo Scientific, Waltham,
MA, USA), single Cytofunnel disposable sample chambers, and metal slide holders, along with sterile saline
solution (0.9% sodium chloride), frosted glass slides,
and sterile Pasteur transfer pipettes. Residual fluid is
absorbed by the sample chamber's filter card, which
flattens the cells into a monolayer onto the slide preserving their integrity, and making single cells easier
to detect. The slide can then be air-dried, stained and
examined. For preparation of the samples, we followed
the standard protocol, which is described below.
The first steps include turning the Cytospin centrifuge on, lifting the top cover and removing the protective lid on the inside of the centrifuge [2,9]. Frosted
slides are first labeled with the patient’s name, medical
record number, and date, and then placed into the slide
C

Fig. 2. (A) Cytospin and (B, C) inside view showing the special rotor for proper insertion of the Cytospin slide.

A

B

C

D

Fig. 3. Preparing for the Cytospin procedure. (A) Mixing the sample. (B) Slide mounted on metal Cytospin slide holder. (C) Droplet of semen sample added to Cytofunnel. (D) Two drops of sterile saline added to Cytofunnel of “blank” control slide.
www.wjmh.org
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holder (Fig. 2A). The Cytofunnel filter is then placed
directly on top of the slide with the frosted side up.
Each Cytofunnel filter and slide are paired and then
placed into the Cytospin slide holder. After firmly locking with the slide holder's mechanism, the assembled
apparatus is positioned upright in the cytocentrifuge
slot. Conventionally, slides are labeled as “C” for the
Cytospin patient sample, while 1 slide is labeled as “B”
for the blank control. The control is prepared in a similar manner as the patient slides, except that it does not
include any patient sample. Using a sterile transfer
pipette, one drop of the well-mixed patient sample is
added into the top opening of the Cytofunnel, followed
by one drop of sterile saline in each Cytofunnel. If
the specimen is highly viscous, one drop of the semen
sample is placed in the Cytospin chamber, and 2 drops
of sterile saline are added. For the blank control, two
drops of sterile solution are added to the slide, without
adding any semen sample (Fig. 3). After the top of the
Cytofunnel is securely capped, the assembled slides
and Cytofunnel apparatuses are placed into the appropriate slots inside the centrifuge. The protective lid is
reinserted inside the centrifuge and locked into place.
Next, the top cover is closed and the light on the display comes on to indicate that the cover was properly
locked. The sample is centrifuged at 500 g for 10 minutes.
Precaution should be taken when adding the patient
sample to ensure that the fluid is in the horizontal
tunnel of the Cytofunnel and not in the vertical coneshaped part of the tunnel. No more than 0.5 mL of
fluid should be used, as this is the maximum amount
that the tunnel can hold. If more than 0.5 mL of
sample volume is loaded in the cone-shaped vertical

A

Nuclear fast stain

1

2

3
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Dissolve 5 g of aluminum
sulfate in 200 mL of hot
distilled water

Add 0.1 g of nuclear fast red
and stir with a glass rod
Cool and filter

Store at room temperature
Stain is stable for 6 8 months
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portion of the tunnel, it will be forced up the cone during centrifugation and will not get concentrated onto
the slide. Caution is also exercised to avoid placing the
fingers over the small hole in the center of the closure
cap when placing it onto the tunnel. Placing the finger
forces the fluid in the horizontal tunnel immediately
onto the slide before centrifugation and reduces cell
recovery.
After centrifugation, the top cover is opened, and the
protective lid and the slide apparatuses are removed.
The slide holder with the attached Cytofunnel are laid
horizontally on a table. With the slides still locked inside, they are allowed to dry for approximately 5–10
minutes. Next, the Cytofunnel is unlocked, and discarded into a biohazard bin. The slides are allowed to
air-dry for an additional 15 minutes before staining, in
case fluid remains in the sample chamber after spinning. A quality control slide is also prepared by making a smear of a healthy donor semen sample, which is
stained with NF-PIC stain along with the other slides.

5. Preparation of samples for NF-PIC staining

The utility of the NF-PIC staining technique in detecting sperm at small concentrations has been demonstrated by serial dilution of semen samples [10].
The first step in this procedure includes preparing
the NF-PIC staining as shown in Fig. 4. In this study,
all the reagents listed in Fig. 4 were supplied by SigmaAldrich (St. Louis, MO, USA). Labeled slides for patients, quality control, and blank are placed face-up on
the staining rack. By using a sterile Pasteur pipette, a
sufficient amount of absolute ethanol (fixative) is used
to fully cover each of the slides for 15 minutes (Fig.
5A). The slides are then positioned upright allowing

Picroindigocarmine stain

1

2

3

Add 150 mL of saturated picric
acid solution to a glass beaker

Dissolve 0.5 g of indigocarmine
dye in the solution (light sensitive)
Filter and store in a brown bottle

Store at room temperature
Stain is stable for 6 8 months
2021

Fig. 4. Schematic of steps in the preparation of (A) nuclear fast stain and (B)
picroindigocarmine stain.
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A

B

C

Fig. 5. Steps in staining the slides for NF-PIC. (A) Fixing the slides with ethanol for 15 minutes, (B) flooding the slide with nuclear fast stain for 15
minutes, and (C) replacing with picroindigocarmine stain for 30 seconds. NF-PIC: nuclear fast picroindigocarmine.

Mounting media

Lint-free wipes

Bright-field microscope

Immersion oil

the ethanol to drain off and air-dried for 15 minutes.
The slides are laid flat on the staining rack, and a sufficient amount of NF solution is placed to cover each
slide for 15 minutes (Fig. 5B). The NF solution from the
slide is removed by tilting the slide and the solution is
allowed to drain off. The slides are laid flat again on
the staining rack, and several drops of PIC staining are
placed on the NF-stained slide (Fig. 5C). After 30 seconds of staining with PIC, the excess stain is rinsed off
with absolute ethanol, and the slides are allowed to airdry for 15 minutes. Afterwards, a few drops of Cytoseal
mounting media are added, a cover slip is gently placed
and allowed to air dry again. The slides are cleaned
with lint-free wipes and lens cleaner solution. A drop
of immersion oil is placed, and slides are observed
for the presence of spermatozoa under a bright-field
microscope at 100× magnification (Fig. 6). In this tech-

Lens cleaner solution

Fig. 6. The NF-PIC stained slide observed
under a bright-field microscope using
immersion oil and mounting media. The
slide is cleaned with lens cleaner solution or lint-free wipes. NF-PIC: nuclear
fast picroindigocarmine.

nique, sperm heads stain red and tails green, allowing
spermatozoa to be more easily identified when viewed
microscopically.
The results are reported as:
a) No sperm seen: when no sperm are observed after
staining.
b) Sperm seen: if sperm with distinct tails (Fig. 7) or
only sperm heads are seen.

6. Quality control in NF-PIC staining test

A semen sample with normal semen characteristics
obtained from a healthy male volunteer is utilized to
prepare slides for quality control of NF-PIC staining
along with each set of patient slides. The donor slide is
first examined and checked for quality of staining. The
sperm head should stain pink and the tail green. Once
the quality of the stain is considered acceptable, then

www.wjmh.org
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the patient slides are examined for the presence or absence of sperm.

7. Statistical analysis

Descriptive statistics were used to present the outcome of the NF-PIC technique with positive results
(sperm detected) being reported as percentage of total
number of samples tested (MedCalc Statistical Software, ver. 17.8; MedCalc Software, Ostend, Belgium).

RESULTS
During the study period, 251 azoospermic men were
tested using Cytospin and NF-PIC staining. Of these
251 samples, sperm were detected in 60 (23.9%) patients
while 191/251 (76.1%) were negative for sperm (Table 1).
Of the 251 men who did not show sperm in the initial
semen analysis, only 46 men (18.3%) opted for further
therapy at the Cleveland Clinic, and underwent microdissection testicular sperm extraction (mTESE) for
sperm extraction and intracytoplasmic sperm injection
(ICSI). These included 13 men in whom sperm had been
detected by NF-PIC, and sperm were found on mTESE
in 9/13 (69.2%) of them. The remaining 33 patients did
not show sperm after NF-PIC testing. Clinical details of
testicular histology, fertilization and pregnancy rates
were not available.

DISCUSSION
An accurate diagnosis of azoospermia is important to
establish the etiology of the infertility and plan appropriate management options [2,11]. When no sperm are
detected in the initial semen evaluation, the sample

632
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Fig. 7. Smear showing presence of
sperm after NF-PIC staining (magnification, 1,000×). NF stains sperm head pink
(indicated by arrow). NF-PIC: nuclear fast
picroindigocarmine.

Table 1. Distribution of 251 azoospermic men tested by NF-PIC staining and 46 men who opted for sperm retrieval by mTESE or cTESE for
NOA
Subject
Patient
Undergo surgery
Surgery+
Surgery-

Total subjects with azoospermia (n=251)
NF-PIC positive
60 (23.9)
13
9 (69.2)
4 (30.8)

NF-PIC negative
191 (76.1)
33
13 (39.4)
20 (60.6)

Values are presented as number (%) or number only.
cTESE: conventional testicular sperm extraction, mTESE: microsurgical testicular sperm extraction, NF-PIC: nuclear fast picroindigocarmine, NOA: nonobstructive azoospermia, Surgery+: sperm seen,
Surgery-: no sperm seen.

has to be centrifuged and the pellet examined. The
4th, 5th, and 6th editions of the WHO manual [4-6] adopted the definition of azoospermia as first proposed
by Eliasson et al [12] in 1981: “no spermatozoa found in
the sediment of a centrifuged sample”. The American
Urological Association (AUA) defines azoospermia as
the absence of sperm from at least two separate centrifuged semen samples, with “no sperm after centrifugation at 3,000 g for 15 minutes and examination of the
pellet” [13]. The American Society for Reproductive
Medicine (ASRM) guidelines for evaluation of azoospermia diagnose azoospermia when no spermatozoa
can be detected on high-powered microscopic examination of a pellet after centrifugation of the seminal fluid
on at least two separate occasions [14,15].
Centrifugation helps concentrate rare sperm into a
small pellet in order to increase the chances of their
detection. The importance of this was demonstrated by
Jaffe et al [16] who reported that 22.8% of men with

Rakesh Kumar Sharma, et al: Nuclear Fast Picroindigocarmine Staining

non-obstructive azoospermia and 18.6% of men who
had been operated for obstructive azoospermia, with no
sperm seen on wet mount light microscopy, had spermatozoa in the pellet produced by centrifugation at
200 g for 10 minutes. Interestingly, sperm were found
in the pellet of one sample but not in the pellet from a
second sample in 41.2% of the obstructive azoospermic
group and 11.8% of the non-obstructive group.
The Cytospin technology used in this study is unique
in sedimenting the sample into a small (32 mm2) easily
identifiable area for NF-PIC staining [9,17]. Cytospin
was originally developed by Shandon and later bought
by the company Thermo Scientific. This is an instrument suited for cell concentration by sediment analysis
of many fluids. Initially, it was used to analyze the
presence of exfoliated germ cells in semen samples for
the identification of carcinoma of the testis in situ.
Different centrifugation speeds and times have been
used to detect the presence or absence of sperm [1721] (Table 2), with variable results depending on the
centrifugation time and speed [16,22] and volume of
the pellet examined. Although WHO 5th Edition recommendation for spinning the neat sample at 3,000 g for
15 minutes was based on the study published by Corea
et al [5,19], speed or time was not recommended by the

authors of that study. In their study, Corea et al [19]
demonstrated that no sperm were seen in the pellets
produced at 600 g for 10 minutes. When the supernatant, obtained from the 600 g step, was further centrifuged at 1,000 g for 15 minutes, sperm could be found
in the pellet of this sample. The 1,000 g supernatant
was then centrifuged at 3,000 g for 15 minutes but no
additional sperm were found. Their study concluded
that semen samples labelled as azoospermic as per
initial wet mount microscopy examination should be
centrifuged at a minimum of 1,000 g for 15 minutes to
allow adequate sperm detection.
NF-PIC staining after centrifugation for detecting
the presence of sperm in an azoospermic sample was
first reported in 1998 [2] when the authors could detect
sperm in the semen of 9/20 (45%) men with histologically proven testicular failure. The utility of NF-PIC
staining was also demonstrated by Tanil et al [20], who
compared the outcomes between examination of pelleted semen by wet mount phase contrast microscopy
and after NF-PIC staining. Sperm were found in 14.3%
of the pellets examined under phase contrast microscopy and in 53.6% of the samples examined after NFPIC staining. In our present study, comprising of a
larger sample size (n=251), sperm were found in 23.9%

Table 2. Centrifugation speed and time used to confirm azoospermia
Reference
[18]
[2]

Centrifugation
Speed

Time (min)

[16]

1,000 g
300 g
Cytospin 500 g
200 g

15
7
10
10

[4-6]
[21]

3,000 g
1,000 g

15
15

[19]

600 g
1,000 g
3,000 g

10
15
15

[20]

700 g

15

[17]

3,000 g
2,000 g

15
15

Comment
After centrifugation motility can be lost
Sample centrifuged at 300 g for 7 minutes
Cytospin at 500 g for 10 minutes
Whole pellet examined under high-power fields. 18.6% of men with OA and 22.8% of men with NOA
before centrifugation had spermatozoa in the pellet
Based on the study by Corea et al [19]
Sample centrifuged at least 1,000 g for 15 minutes and the pellet examined under the 40× objective
using phase contrast optics
Step 1: Study reported no sperm in the pellets produced at 600 g
Step 2: Detected spermatozoa in the 600 g supernatants when centrifuged at 1,000 g
Step 3: No further sperm-containing samples detected by centrifuging the 1,000 g supernatant at
3,000 g for 15 minutes
The authors concluded that 1,000 g for 15 minutes was adequate for detecting sperm
Samples retrieved from NOA patients had positive results in 53.6% after NF-PIC staining
Samples retrieved from suspected OA patients had positive results in 14.3% after NF-PIC staining
Initial detection of sperm
When no sperm was detected, sample was then prepared by microcentrifugation and stained with NFPIC for detecting presence of sperm
Concluded that centrifugation at 3,000 g damaged the sperm integrity

NF-PIC: nuclear fast picroindigocarmine, NOA: nonobstructive azoospermia, OA: obstructive azoospermia.
www.wjmh.org
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of men who had been diagnosed as azoospermic using
the standard methodology [5].
Alternatively, in a study by Monteiro et al [17], the
samples were centrifuged at 3,000 g for 15 minutes.
In samples where no sperm were detected, a modified
micro-centrifugation technique was used, where the
sample was further centrifuged at 2,000 g for 15 minutes. The entire pellet was then spread on a 4×6 mm
area of the slide, and stained with NF-PIC. In their
study, 148 azoospermic samples were examined and 21
samples (14.2%) were identified as sperm-positive [17].
Some studies have recommended using modified supersensitive fluorescent assays to determine the presence of sperm in azoospermic samples [23,24].
Detection of rare sperm in samples that have been
labelled azoospermic has important clinical implications in diagnosis and further management. First, it
rules out complete obstruction as a cause of the azoospermia, and establishes a diagnosis of cryptozoospermia due to testicular failure (excepting a rare case of
partial obstruction). Second, it suggests that, on the day
of oocyte pick-up, the IVF laboratory could conduct an
extended search for sperm in the ejaculate for use in
ICSI [25]. Third, the detection of rare sperm in the ejaculate may predict a higher chance of sperm retrieval
if mTESE is performed. In fact, Alrabeeah et al [26]
reported sperm recovery by mTESE in 23 of 24 (95.8%)
men with cryptozoospermia. In our study sperm were
recovered in 69.2% of apparently azoospermic men
when some sperm were detected by NF-PIC. However,
these numbers are too small to draw any definitive
conclusions.

yet be identified in the semen following additional centrifugation and staining, thus changing the diagnosis
to cryptozoospermia. This has significant clinical implications. In this study, we have demonstrated the utility
of Cytospin microcentrifugation combined with NF-PIC
staining. The method presented here is simple and rapid, can be implemented by any laboratory, and can be
recommended as a useful additional step in the evaluation of azoospermia. Comparison with other methods
of centrifugation and staining should be performed in
future to determine the best technique for identifying
rare sperm in the semen.

Limitations of current study

Data Sharing Statement

Despite the interesting findings of the current study,
few limitations are noted. First, the retrospective nature of this study precluded us from including a control group of patients that used different cytocentrifugation or staining techniques. Second, we have limited
follow-up data related to the reproductive outcome of
the study population which prevents any conclusion
on the role of the NF-PIC technique in predicting the
reproductive outcomes of surgically retrieved sperm.
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